Measurement and Comparison of Costs of Hypertensive Patients Aged 40-89 Years Treated with Lisinopril and Perindopril

1. Ordinance No 04-07-1 of Mar, 29, 2016 for correction and in addition to Ordinance N0 04-24-1: Published by Ministry of Health. State Gazette. 2016 Mar, 25.Search in Google Scholar

2. National Council on Prices and Reimbursement of Medical Products. Positive Drug List 2017 [Internet]. Sofia 2017 [cited 2017 June 16]. Available from: http://www.ncpr.bg/bg/Search in Google Scholar

3. Ministry of Health. [National Framework Contract between NHIF and BMA – 2015]. State Gazette Issue 25 as of March 31, 2016. BulgarianSearch in Google Scholar

4. Government Decree No 193 of Aug, 28, 2012. Published by Council of Minister of the Republic in Bulgaria. State Gazette.2012 Sept, 4Search in Google Scholar

5. Government Decree No 312 of Dec, 27, 2013 for correction and in addition to Government Decree N0 193 of Aug, 28, 2012. Published by Council of Minister of the Republic in Bulgaria. State Gazette. 2014 Jan, 7.Search in Google Scholar

6. Drummond M, O’ Brien BJ, Stoddart G, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 3^rd ed. Oxford: University Press, 2005.Search in Google Scholar

7. Center of Emergency Medical Care – Pleven. [Specification of ambulance]. p. 3. Bulgarian.Search in Google Scholar

8. Ministry of Health of the Republic of Bulgaria. [Concept “Objective for Health 2020”], Sofia; 2015. BulgarianSearch in Google Scholar

9. [Payment methods of health services in hospital care.] Published by Council of Minister of the Republic in Bulgaria. State Gazette, 2015 Mar, 20. Bulgarian.Search in Google Scholar

10. Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press. 2002;11(1):35-45.10.1080/08037050275354394511926349Search in Google Scholar

11. Bulgarian Society of Internal Medicine. [National Association of general practitioners in Bulgaria, Bulgarian Hypertension league. Guideline of the Management of the Arterial hypertension for general practitioners]. Sofia: National Association of general practitioners in Bulgaria; 2007. BulgarianSearch in Google Scholar

12. Marinov L. [Arterial hypertension and salt intake]. Science Cardiology 2009;3:100-102. BulgarianSearch in Google Scholar

13. Moran A, Odden M, Thanataveerat A, Tzong K, Rasmussen P, et al. Cost-effectiveness of Hypertension Therapy According to 2014 Guidelines. N Engl J Med. 2015;372(17):1677.10.1056/NEJMx15001625901443Search in Google Scholar

14. Naser N, Dzubur A, Durak A, Kulic M, Naser N. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Med Arch. 2016;70(4):274-9.10.5455/medarh.2016.70.274-279503497727703288Search in Google Scholar

15. Torbova S, Gocheva N, Sirakova V, Tarnovska R, Donova T, Vlahov V. [Consensus of monotherapy and combination therapy of patients with Arterial Hypertension in Bulgaria]. Bulgarian Cardiology 2005;5(11), 1-31. Bulgarian.Search in Google Scholar

16. Georgiev B, Genov A, Baitcheva V, Kostova E. [Combination therapy in essential hypertension: contemporary approach to combine calcium antagonists and beta-blockers]. Science Cardiology 2014;15(5):231-239. Bulgarian.Search in Google Scholar

17. Vekov T. [Stimulation of generic drugs prescription – the shortest way to cut public and personal costs for medical products]. General medicine journal 2009;11(3):14-16. Bulgarian.Search in Google Scholar

18. Raev D, Barkalova D. Initial antihypertensive therapy in Bulgaria. A National prospective, observational study (BP-Initial Therapy-BG study). Journal of Hypertension. 2015;33 Suppl 1.10.1097/01.hjh.0000468812.64567.15Search in Google Scholar

19. Vekov T. [Analysis of reimbursement expenditures of the National Health Insurance Fund for medical products for home therapy]. General medicine journal 2012;14(3):23-29. Bulgarian.Search in Google Scholar

20. Gocheva N. [Initial therapy of arterial hypertension by combined drug with low dosage]. Science Cardiology 2005; 3:100-104. Bulgarian.Search in Google Scholar

21. Bian B, Kelton C, Guo J, Wigle P. ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008. J Manag Care Pharm. 2010;16(9):671-9.10.18553/jmcp.2010.16.9.67121067253Search in Google Scholar

22. Consumer Report Health. Using ACE inhibitors to treat: High Blood Pressure and Hearth Disease – Companying Effectiveness, Safety and Price, 19 p.Search in Google Scholar

23. Lee P, Robin K, Chan J, Chang S, Lee SC, Tomlinson B. A prescription survey in a hospital hypertension outpatient clinic. Br J Clin Pharmacol. 1997;44:577-2.10.1046/j.1365-2125.1997.t01-1-00621.x20428929431835Search in Google Scholar

24. Ivanova A, Petrova G. Hypertension and common complications – analysis of the ambulatory treatment cost. Cent Eur J Public Health. 2009;17(4):223-0.10.21101/cejph.a353820377054Search in Google Scholar

25. Moreira GC, Cipullo JP, Martin JF. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study. J Hypertens. 2009;27:1900-7.10.1097/HJH.0b013e32832dd10f19587607Search in Google Scholar

26. Dias da Costa JS, Fuchs SC, Olinto MT. Cost-effectiveness of hypertension treatment: a population-based study. Sao Paulo Med J. 2002;120(4):100-4.10.1590/S1516-3180200200040000212436155Search in Google Scholar

27. Krzysztoszek J, Koligat D, Ratajczak P, Bryl W, Cymerys M, Hoffmann K, et al. Piotr Ratajczak1, Wieslaw. Economic aspects of hypertension treatment in Poland. Arch Med Sci. 2014;10(3):607-7.10.5114/aoms.2013.32853410723925097594Search in Google Scholar

28. Heidenreich PA, Davis BR, Cutler JA. Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of theAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Gen Intern Med. 2008; 23(5):509-6.10.1007/s11606-008-0515-2Search in Google Scholar

29. Azarisman SMS, Aszrin A, Sahimi M, Ngow HA, Marzuki AO, Jamalludin AR, et al. Evaluation of antihypertensive drug utilization and cost in Hospital Tengku Ampuan Afzan, Kuantan. IMJ. 2009;8(2):29-35.Search in Google Scholar

30. Small RE, Freeman-Arnold SB, Goode JV, Pyles MA. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents. Pharmacotherapy. 1997;17(5):1011-6.Search in Google Scholar

31. Rizzo JA, Abbott TA, III, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ. 1996;5(3):249-5.10.1002/(SICI)1099-1050(199605)5:3<249::AID-HEC203>3.0.CO;2-ASearch in Google Scholar

32. National Institute for Health and Clinical Excellence. Hypertension: Cost Report – Implementing NICE Guidance 2011. London: NICE Midcity Place; 2011.Search in Google Scholar